The first study was a 24-week, randomized, multicenter, noninferiority trial in patients with T1D that investigated the effects of TI in combination with basal insulin (SC long-acting insulin analogs) (n = 174) compared with patients treated with SC insulin aspart in combination with basal insulin (n = 171) [61]. Here, INS is linked to type 1 diabetes mellitus.